Breast Carcinoma In Situ

subtype

Identifier: CI-CAN-00004667
Entity page: /cancer/breast-carcinoma-in-situ ↗
Edges: 220

Neighbours: 23 drugs10 trials
Drawn: 33 of 33 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Breast Carcinoma In Situ investigated for …INVESTIGATED_FOR9 of 9
← investigated for	Pembrolizumabmonoclonal_antibody	unknown	3	Breast Carcinoma In Situ	1	Curated	chembl	graph →
← investigated for	Paclitaxelsmall_molecule	unknown	2

Breast Carcinoma In Situ investigated in trials for …INVESTIGATED_IN_TRIALSderived17 of 17show fewer
→ investigated in trials for	Tamoxifensmall molecule 13 trials (6 active) · roll-up of the cancer and its descendants	—	—	Breast Carcinoma In Situ	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Letrozolesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Breast Carcinoma In Situ	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Afimoxifenesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Breast Carcinoma In Situ	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Anastrozolesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Breast Carcinoma In Situ	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Exemestanesmall_molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Breast Carcinoma In Situ	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Hormone Therapy 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Breast Carcinoma In Situ	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Lapatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Breast Carcinoma In Situ	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Metforminsmall_molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Breast Carcinoma In Situ	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Trastuzumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Breast Carcinoma In Situ	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Abemaciclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Breast Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Aromatase Inhibitor 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Breast Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Bexarotenesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Breast Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Chloroquinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Breast Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Palbociclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Breast Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumabmonoclonal_antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Breast Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ruxolitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Breast Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Zoledronic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Breast Carcinoma In Situ	1	Observed	clinicaltrials	graph →

Breast Carcinoma In Situ investigated in trials for …INVESTIGATED_IN_TRIALSderived17 of 17show fewer

→ investigated in trials for

Tamoxifensmall molecule

13 trials (6 active) · roll-up of the cancer and its descendants

—

Breast Carcinoma In Situ

Observed

Breast Carcinoma In Situ studied in …STUDIED_INderived10 of 194show all (up to 200)
→ studied in	NCT04570956Phase 2 · terminated Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk · condition mapped ONTOLOGY_EXACT · 194 trials mapped (72 active)	—	—	Breast Lobular Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT07408856Phase 1 · recruiting CAN1012 in Pre-Malignant DCIS and LCIS · condition mapped ALIAS · 194 trials mapped (72 active)	—	—	Breast Lobular Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT07711847NA · recruiting Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy · condition mapped ALIAS · 194 trials mapped (72 active)	—	—	Breast Ductal Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT02620852NA · recruiting Women Informed to Screen Depending on Measures of Risk (Wisdom Study) · condition mapped ONTOLOGY_EXACT · 194 trials mapped (72 active)	—	—	Breast Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT04084730Phase 2 · recruiting Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer · condition mapped ALIAS · 194 trials mapped (72 active)	—	—	Breast Ductal Carcinoma In Situ, Low Grade	1	Observed	clinicaltrials	graph →
→ studied in	NCT03077841Phase 2/Phase 3 · suspended Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer · condition mapped ALIAS · 194 trials mapped (72 active)	—	—	Breast Ductal Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT06033092Phase 2 · completed Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion · condition mapped ALIAS · 194 trials mapped (72 active)	—	—	Breast Lobular Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT06902311Phase 2 · recruiting Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST) · condition mapped ALIAS · 194 trials mapped (72 active)	—	—	Breast Ductal Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT02750826Phase 3 · active not recruiting Breast Cancer WEight Loss Study (BWEL Study) · condition mapped ONTOLOGY_EXACT · 194 trials mapped (72 active)	—	—	Breast Ductal Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT03317405Phase 1 · active not recruiting Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery · condition mapped ONTOLOGY_EXACT · 194 trials mapped (72 active)	—	—	Breast Carcinoma In Situ	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains